Asia-Pacific Interventional Imaging Market – Industry Trends and Forecast to 2031

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Asia-Pacific Interventional Imaging Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Apr 2024
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia Pacific Interventional Imaging Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 1.25 Billion
Diagram Market Size (Forecast Year)
USD 2.45 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Asia-Pacific Interventional Imaging Market, Offering (Interventional Imaging System, Interventional Imaging Software, Consumables), Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynaecology, Others), End User (Hospitals, Ambulatory Surgical Centres, Clinics) - Industry Trends and Forecast to 2031.

Asia-Pacific Interventional Imaging Market Analysis and Size

The interventional imaging market is experiencing robust growth driven by technological advancements, increasing chronic disease prevalence, and demand for minimally invasive procedures. Key players such as GE Healthcare, Siemens Healthineers, and Philips Healthcare dominate the market with innovative products such as angiography systems, MRI-guided interventions, and interventional radiology equipment. Rising healthcare investments and a shift towards value-based care are further propelling market expansion globally.

Data Bridge Market Research analyses that the Asia-Pacific interventional imaging market, which was USD 1.25 billion in 2023, is expected to reach USD 2.45 billion by 2031, and is expected to undergo a CAGR of 8.78% during the forecast period of 2024-2031. “Interventional imaging system” dominates the market as the prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders is increasing in the Asia-Pacific region. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Pricing in USD. Volumes in Units

Segments Covered

Offering (Interventional Imaging System, Interventional Imaging Software, Consumables), Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynaecology, Others), End User (Hospitals, Ambulatory Surgical Centres, Clinics)-

Countries Covered

China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and the Rest of Asia-Pacific.

Market Players Covered

Siemens Healthineers Ag (Germany), Ge Healthcare (United States) Philips Healthcare (Netherlands), Shimadzu Corporation (Japan), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Hologic, Inc. (United States), Carestream Health, Inc. (United States), Agfa-Gevaert Group (Belgium), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan)etc.

Market Opportunities

  • Expansion in Emerging Markets
  • Integration with Telemedicine and Remote Monitoring

Market Definition

The Interventional Imaging products are medical devices used during minimally invasive procedures to visualize internal structures and guide interventions. They aid in accurate diagnosis, treatment planning, and precise delivery of therapeutic interventions during procedures. Utilize various modalities such as X-ray fluoroscopy, CT, MRI, and ultrasound to generate real-time images. Equipped with navigation systems for precise manipulation of medical devices within the body, including image overlay, virtual navigation, and tracking technologies. Compatible with a range of interventional devices and accessories for seamless coordination between imaging and intervention.

Asia-Pacific Interventional Imaging Market Dynamics

Drivers

  • Technological Advancements

Technological advancements in medical imaging, such as the development of higher-resolution sensors, improved image processing algorithms, and the integration of artificial intelligence (AI), are significant drivers in the intervention imaging system market. These advancements lead to enhanced imaging quality, accuracy, and speed, ultimately improving patient outcomes and increasing the efficiency of medical procedures. As healthcare providers seek to adopt the latest technology to stay competitive and provide better care, the demand for intervention imaging systems with cutting-edge features continues to rise.

  • Growing Demand for Minimally Invasive Procedures

There is a growing trend towards minimally invasive procedures across various medical specialties. Minimally invasive techniques offer numerous benefits, including shorter recovery times, reduced risk of complications, and improved patient comfort compared to traditional open surgeries. Interventional imaging systems play a crucial role in guiding minimally invasive procedures, providing real-time visualization of internal structures and precise navigation for clinicians. As the demand for minimally invasive interventions continues to increase, so does the demand for high-quality intervention imaging systems.

Opportunities

  • Expansion in Emerging Markets

Emerging markets present significant opportunities for intervention imaging system manufacturers. As healthcare infrastructure improves and disposable incomes rise in these regions, there is a growing demand for advanced medical technologies, including intervention imaging systems. Moreover, the expanding range of applications for intervention imaging systems, such as in cardiology, oncology, and orthopaedics, opens up new market opportunities. Targeting emerging markets and adapting products to meet specific regional needs, companies can tap into these opportunities for growth and market expansion.

  • Integration with Telemedicine and Remote Monitoring

The increasing adoption of telemedicine and remote patient monitoring presents an exciting opportunity for intervention imaging system manufacturers. Integrating intervention imaging systems with telemedicine platforms and remote monitoring devices, healthcare providers can extend their reach beyond traditional healthcare settings. This integration allows for remote consultations, real-time collaboration between clinicians, and the delivery of specialized care to patients in remote or underserved areas. As telemedicine continues to gain traction globally, intervention imaging systems that facilitate remote diagnosis and treatment planning stand to benefit from this trend and capitalize on new market opportunities.

Restraints/Challenges

  • Cost Barrier to Adoption

The interventional imaging market faces that the intervention imaging system market is the high cost associated with acquiring and maintaining these advanced systems. The initial investment required for purchasing intervention imaging equipment, along with ongoing expenses for maintenance, upgrades, and staff training, can pose a significant financial burden for healthcare facilities. This cost barrier may deter some healthcare providers, particularly those in resource-constrained settings, from adopting these cutting-edge technologies, thereby limiting market growth.

  • Interoperability and Integration Issues

A challenge in the intervention imaging system market is ensuring seamless interoperability and integration with other medical devices, healthcare IT systems, and electronic health records (EHR) platforms. As healthcare facilities adopt more digital solutions and strive for interoperability to improve workflow efficiency and patient care coordination, compatibility issues between different systems can arise.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

  • In September 2023, Canon Medical unveiled the Alphenix Sky 12 HD interventional system featuring a novel 12" x 12" High-Definition (Hi-Def) Detector. This Alphenix Sky 12 HD, featuring a 12"×12" Hi-Def detector, offers enhanced visualization capabilities for a range of medical procedures including Interventional Cardiology (IC), Interventional Neurology (IN), Interventional Oncology (IO), and Interventional Radiology (IR), including pediatric interventions

Asia-Pacific Interventional Imaging Market Scope

The market is segmented into three notable segments based on offering, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Offering

  • Interventional Imaging Systems
  • Interventional Imaging Software
  • Consumables

Application

  • Cardiology
  • Neurology
  • Musculoskeletal
  • Oncology
  • Urology
  • Gastroenterology
  • Obstetrics
  • Gynaecology
  • Others

End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics

Asia-Pacific Interventional Imaging Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by offering, application, and end user as referenced above.

The countries covered in the market report are China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and the Rest of Asia-Pacific.

Japan dominates the market because of the strong base of healthcare facilities, the strong presence of major players in the market and the extraordinary healthcare infrastructure.

India and Singapore is expected to witness significant growth during the forecast period of 2024 to 2031 due to increasing awareness, rising cancer disease prevalence, and expanding healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Asia-Pacific Interventional Imaging Market Share Analysis

The market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the market are:

  • Siemens Healthineers Ag (Germany)
  • Ge Healthcare (U.S.)
  • Philips Healthcare (Netherlands)
  • Shimadzu Corporation (Japan)
  • Canon Medical Systems Corporation (Japan)
  • Fujifilm Holdings Corporation (Japan)
  • Hologic, Inc. (U.S.)
  • Carestream Health, Inc. (U.S.)
  • Agfa-Gevaert Group (Belgium)
  • Toshiba Medical Systems Corporation (Japan)
  • Hitachi Medical Corporation (Japan)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Asia-Pacific Interventional Imaging Market size will be worth USD 2.45 billion by 2031.
The Asia-Pacific Interventional Imaging Market growth rate will be 8.78% by 2031.
Technological Advancements and Growing Demand for Minimally Invasive Procedures are the growth drivers of the Asia-Pacific Interventional Imaging Market.
The offering, application and end-user are the factors on which the Asia-Pacific Interventional Imaging Market research is based.
The major companies in the Asia-Pacific Interventional Imaging Market are Siemens Healthineers Ag (Germany), Ge Healthcare (United States) Philips Healthcare (Netherlands), Shimadzu Corporation (Japan), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Hologic, Inc. (United States), Carestream Health, Inc. (United States), Agfa-Gevaert Group (Belgium), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan) etc.